房静远

上海交通大学讲席教授,交大医学院二级教授和博导、附属仁济医院主任医师;上海交通大学医学院附属仁济医院副院长、消化病中心主任;上海市消化疾病研究所长;上海交通大学医学院消化科学院院长、上海市消化内科临床医学中心主任、上海市消化内科临床质控中心主任, 国家卫健委内科消化重点实验室主任上海交通大学讲席教授,交大医学院二级教授和博导、附属仁济医院主任医师;上海交通大学医学院附属仁济医院副院长、消化病中心主任;上海市消化疾病研究所长;上海交通大学医学院消化科学院院长、上海市消化内科临床医学中心主任、上海市消化内科临床质控中心主任, 国家卫健委内科消化重点实验室主任。


学术任职:

中华医学会消化病学分会候任主任委员、亚太消化病学会理事、中国医师协会消化医师分会副会长、上海市消化学会名誉主任委员、上海市医师协会消化医师分会会长。曾任国务院学位委员会学科评议组成员、国家自然科学基金委咨询委员。


科研成果:

以独立通讯作者或Last author通讯作者在Cell、Cell Metab、 Nat Microbiol、Cell Host Microbe、Lancet Oncol、Lancet GH、Cancer Discovery、Gastroenterology、Gut等期刊发表论文185篇;是爱思唯尔和科睿维安高被引学者。《胃肠病学》常务副主编,《中华消化内镜杂志》和《中华消化杂志》及《Frontiers of Medical Sciences in China》等8本学术期刊编委。


研究方向:

从事胃肠癌及其癌前疾病诊治的临床工作,首先证实通过分析肠菌判断大肠癌术后化疗效果与预后、率先证明叶酸和小檗碱及他汀等传统药物具有预防胃肠癌的作用;


个人荣誉:

国家杰出青年基金获得者、教育部“长江学者”特聘教授、国家自然科学基金委创新研究群体带头人、科技部重点研发专项首席科学家。以第一完成人获2008年和2018年两项国家科技进步二等奖;并获谈家桢生命科学奖(临床医学奖)、全国创新争先奖等。



Shanghai Jiao Tong University Chair Professor, Second-Level Professor and Doctoral Supervisor at the School of Medicine, Chief Physician at Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine; Vice President of Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Director of the Digestive Disease Center; Director of the Shanghai Institute of Digestive Diseases; Dean of the School of Digestive Sciences at Shanghai Jiao Tong University School of Medicine, Director of the Shanghai Clinical Medical Center for Digestive Diseases, Director of the Shanghai Clinical Quality Control Center for Digestive Diseases, and Director of the Key Laboratory of Digestive Diseases of the National Health Commission.

Academic Appointments:
Incoming Chairman of the Chinese Society of Gastroenterology, Council Member of the Asian Pacific Association of Gastroenterology, Vice President of the Chinese Medical Doctor Association Gastroenterology Branch, Honorary Chairman of the Shanghai Society of Gastroenterology, and President of the Shanghai Medical Doctor Association Gastroenterology Branch. Former member of the Academic Degrees Committee of the State Council and consultant for the National Natural Science Foundation of China.

Research Achievements:
Has published 185 papers as the sole corresponding author or last author in journals such as "Cell", "Cell Metabolism", "Nature Microbiology", "Cell Host & Microbe", "The Lancet Oncology", "The Lancet Global Health", "Cancer Discovery", "Gastroenterology", and "Gut". Recognized as a Highly Cited Researcher by Elsevier and Clarivate Analytics. Serves as the Executive Deputy Editor-in-Chief of "Gastroenterology", and editorial board member of 8 academic journals including "Chinese Journal of Digestive Endoscopy", "Chinese Journal of Digestion", and "Frontiers of Medical Sciences in China".

Research Focus:
Engaged in clinical work on the diagnosis and treatment of gastrointestinal cancer and its precancerous diseases. First to demonstrate the use of gut microbiota analysis to predict the efficacy and prognosis of chemotherapy in colorectal cancer patients, and pioneered the use of traditional drugs such as folic acid, berberine, and statins for the prevention of gastrointestinal cancer.

Personal Honors:
Recipient of the National Science Fund for Distinguished Young Scholars, Chang Jiang Scholar Distinguished Professor of the Ministry of Education, Leader of the National Natural Science Foundation of China Innovation Research Group, and Chief Scientist of the Key Research and Development Program of the Ministry of Science and Technology. Awarded two National Science and Technology Progress Awards (Second Prize) in 2008 and 2018 as the first completer, and received the Tan Jiazhen Life Science Award (Clinical Medicine Award) and the National Innovation and Dedication Award, among others.
出版者信息








《广州医药》公众号